Loading...

VectivBio Holding AG

VECTNASDAQ
Healthcare
Biotechnology
$16.87
$0.02(0.12%)

VectivBio Holding AG (VECT) Stock Overview

Explore VectivBio Holding AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.4/100

Key Financials

Market Cap1.1B
P/E Ratio-7.94
EPS (TTM)$-2.10
ROE-0.57%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$1.71

VECT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of VectivBio Holding AG (VECT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $1.71.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.94 and a market capitalization of 1.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;